FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to use of a pharmaceutical composition for preventing or treating fibrosis. Use of a pharmaceutical composition containing a compound represented by the following Chemical Formula 1
or a pharmaceutically acceptable salt thereof, for preventing or treating fibrosis by administering 100 to 150 mg twice a day (BID).
EFFECT: above described composition is effective for preventing or treating fibrosis.
6 cl, 10 dwg, 15 tbl, 6 ex
| Title |
Year |
Author |
Number |
| AGENT FOR PULMONARY FIBROSIS CONTAINING PYRAZOLE DERIVATIVE |
2021 |
- Moon, Sung Hwan
- Lee, Soo Jin
- Yu, Hyunkyung
- Goh, Yoo-Kyung
|
RU2817989C1 |
| ORVEPITANT FOR CHRONIC COUGH TREATMENT |
2016 |
|
RU2746601C2 |
| THERAPEUTIC USE OF LONG-ACTING TRIPLE AGONIST CONJUGATE HAVING ACTIVITIES ON ALL GLUCAGON/GLP-1/GIP RECEPTORS FOR TREATING LUNG DISEASE |
2020 |
- Lee Seon Myeong
- Lee Jong Suk
- Kim Jung Kuk
- Lee Sang Hyun
- Oh Euh Lim
- Jo Hyo Sang
- Park Eun Jin
- Lim Chong Yoon
|
RU2829342C1 |
| 1-(6-(METHOXY)PYRIDAZIN-3-YL)CYCLOPROPANE-1-CARBOXAMIDE DERIVATIVES AS AUTOTAXIN (ATX) MODULATORS FOR TREATMENT OF INFLAMMATORY AIRWAY DISEASES |
2020 |
- Kuttruff Christian Andreas
- Bretschneider Tom
- Godbout Cedrickx
- Koolman Hannes Fiepko
- Martyres Domnic
- Roth Gerald Juergen
|
RU2830122C2 |
| MATERIALS AND METHODS OF TREATING CHRONIC FIBROUS DISEASES |
2006 |
- Khogaboum Kori M.
- Kunkel' Stiven L.
|
RU2446825C2 |
| COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF DISEASES, CONDITIONS, OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION |
2012 |
- Lender Sintiya
- Brofi Kolin
|
RU2620066C2 |
| THERAPEUTIC AGENT FOR FIBROSIS |
2016 |
|
RU2729630C2 |
| DOUBLE-CHAINED OLIGONUCLEOTIDE SPECIFIC TO CTGF GENE AND COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF FIBROUS DISEASES AND DISEASES ASSOCIATED WITH RESPIRATORY SYSTEM |
2020 |
- Park, Han-Oh
- Kim, Tae-Rim
- Ko, Young-Ho
- Yun, Sung Il
- Park, Jun Hong
|
RU2807108C1 |
| THERAPEUTIC AGENT APPLICABLE IN PULMONARY FIBROSIS |
2009 |
- Niitsu Joshiro
- Takimoto Rishu
|
RU2547571C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD |
2019 |
|
RU2789128C2 |
